ATHERGEN Trademark

Trademark Overview

On Thursday, January 19, 2023, a trademark application was filed for ATHERGEN with the United States Patent and Trademark Office. The USPTO has given the ATHERGEN trademark a serial number of 97761195. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 23, 2024. This trademark is owned by Athergen Inc.. The ATHERGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Vaccine research and development; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
athergen

General Information

Serial Number97761195
Word MarkATHERGEN
Filing DateThursday, January 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements

Goods and ServicesVaccine research and development; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAthergen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, DE 19901
Party NameAthergen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19901

Trademark Events

Event DateEvent Description
Thursday, February 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 23, 2023NEW APPLICATION ENTERED
Monday, May 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Wednesday, January 24, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 24, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

athergen research development vaccines fields immunopharmaceuticals services medicines vaccine engineering testing